This is a limited company view. Sign up for a Free Trial to see everything.

CYTOO is a Contract Research Organization developing more physiological cell-based assays fully compatible with High-Content Screening and High-Content Analysis. CYTOO has pioneered the ability to control cells microenvironment and has developed a platform of micropattern technologies to enable significantly greater physiologically relevant cellular models in comparison to standard techniques used by most labs and CRO's. CYTOO solutions allow for simple conversion of poorly robust and low throughput assays into highly reliable and data rich HCS efforts

B2B
B2C
Biotechnology
Healthcare
Medical Diagnostics
Pharmaceuticals

Overview

Location

Grenoble

Founded

2008

Employees

17

Stage

Series C

Total funding

$15M

Last funding

6 years ago

Acquisitions

0

Growth score

3

Mindshare score

10

Scoring

Deals

$4.7M Series B

Auriga Partners, CEA Investissement

Oct 1, 2009

Employee Growth

Use Cytoo's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Cytoo's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

external advisor and co-founder
Sales Manager
Business Development, Director
Image Analysis Scientist
Research Laboratory Technician
applications specialist
Senior Scientist R&D
Responsable Procédés de Production
PhD student
Research scientist

Similar Companies

BioMarck Pharmaceuticals

BioMarck Pharmaceuticals develops and licenses products targeted at difficult to treat diseases with unmet needs.
Series A

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes